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Since the first case described in 1967 by Robertson
et al, renin-secreting juxtaglomerular cell tumor
(JCT) of the kidney has appeared to be a rare, but
curable cause of hypertension.1 The clinical man-
ifestations of JCT syndrome are clearly established
and comprise hypertension, hyper-reninemia, and
secondary aldosteronism.2 Nonetheless, the diag-
nosis of such tumors remains challenging because
there are considerable ambiguities while interpret-
ing laboratory and radiological studies.3 We report
a patient with JCT whose serum aldosterone level
remained normal despite the existence of typically
high plasma renin activity (PRA). Furthermore, the
response of PRA to a renin-angiotensin system-
blocking agent, renal arteriography, and renal 
venous sampling all failed to present the typical
features of JCT. We also discuss some diagnostic
difficulties, which could be encountered during
investigation of individuals with suspected JCT.
Case Report
A 17-year-old girl was referred to our hospital due
to severe hypertension for 1 year. A family history
of hypertension was present and her hypertension
was first noted during a routine health examina-
tion 1 year prior to this hospitalization. She was
previously well and did not receive any diagnostic
examination or treatment for her hypertension.
©2010 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Departments of 1Internal Medicine and 3Urology, China Medical University Hospital, China Medical University, 2Department
of Urology, Jen Ai Hospital, Taichung, Taiwan.
Received: January 14, 2008
Revised: April 15, 2008
Accepted: June 10, 2008
*Correspondence to: Dr Rong-Hsing Chen, Department of Internal Medicine, China Medical
University Hospital, China Medical University, 2 Yuh-Der Road, Taichung 404, Taiwan.
E-mail: paishulan@yahoo.com.tw
Case Report
Secondary Hypertension due to a Renin-secreting
Juxtaglomerular Cell Tumor
Shih-Yi Lin,1 Wayne-Young Liu,2 Wen-Chi Chen,3 Rong-Hsing Chen1*
A juxtaglomerular cell tumor (JCT) is a rare, renin-secreting tumor of the kidney and can cause hyperten-
sion. JCT is pathologically benign, and resection of the tumor is curative for hypertension. We report the
case of a 17-year-old girl who had hypertension and hypokalemia for 1 year. Laboratory studies showed
increased basal plasma renin activity, but normal serum aldosterone level. Abdominal computed tomog-
raphy disclosed a 2 cm solid mass in the left kidney. However, renal vein sampling and captopril test re-
sults were equivocal. Partial nephrectomy was performed and histologic examination demonstrated
typical features of JCT. Hypertension and hypokalemia completely resolved postoperatively. JCT should be
considered when investigating hypertensive individuals with high plasma renin activity.
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Palpitations and pulsating headaches occasion-
ally accompanied her hypertension. She had no
polydipsia, nocturia, flushing, sweating, visual
disturbance, or any neurological symptoms.
She was 161 cm in height and 74.5 kg in
weight. On admission, her blood pressure was
163/102 mmHg. Physical examination revealed
intact eye fundi and no evidence of cardiac ab-
normalities, coarctation of the aorta, abdominal
bruits, or abdominal masses. There was also no
Cushingoid appearance. Renal function, as judged
by serum creatinine, blood urea nitrogen, and
urine analyses, was not compromised. Electrocar-
diography and chest roentgenography were nor-
mal. The results of a complete blood count and
plasma levels of fasting glucose, cholesterol, so-
dium, calcium, and phosphorus were unremark-
able, except for hypokalemia (3.2 mmol/L). The
24-hour urine sodium and potassium output were,
respectively, 115.6 mmol (normal, 50–250 mmol)
and 44.2 mmol (normal, 25–150 mmol).
A random PRA was markedly increased (11.3ng/
mL/hr; normal, 1.9–3.7 ng/mL/hr), but serum al-
dosterone level was normal (134 pg/mL; normal,
37–240 pg/mL). The diurnal rhythm of serum
cortisol was preserved, with a level of 16.9 μg/dL
at 8 a.m. and 5.6 μg/dL at 4 p.m. The 24-hour
urinary vanillylmandelic acid was 2.8 mg (nor-
mal, 1–7.5 mg). The effects of posture change
and oral captopril (50 mg) on the PRA and serum
aldosterone levels yielded conflicting results. The
PRA and serum aldosterone levels were, respec-
tively, 11.2 ng/mL/hr and 215 pg/mL (aldosterone
normal, 38–307 pg/mL) in the upright posture,
5.09 ng/mL/hr and 222 pg/mL (aldosterone nor-
mal, 29–159 pg/mL) in the supine position, 8.03
ng/mL/hr and 146 pg/mL before oral captopril
intake, and 4.99 ng/mL/hr and 266 pg/mL after
captopril intake.
Intravenous pyelography and renal arteriog-
raphy revealed no evidence of collecting system
distortion or renal artery stenosis, whereas com-
puted tomography of the abdomen disclosed a
small round nodule (17 mm in diameter) in the
middle region of the left kidney (Figure 1). Bilateral
renal venous sampling showed no definitive 
lateralization of PRA (left side, 11.4 ng/mL/hr;
right side, 8.7 ng/mL/hr; left to right ratio: 1.3). A
renin-secreting tumor originating in her left kidney
was highly suspected.
We performed partial resection of the patient’s
left kidney on Day 12 after admission and resected
a well-defined nodule measuring 2.0×2.0×1.4 cm
in size. Microscopically, the tumor, which was
circumscribed by a thick fibrous capsule, con-
sisted of polygonal tumor cells with abundant eo-
sinophilic cytoplasm arranged in an organoid
pattern within vascular stroma (Figure 2A). Im-
munohistochemically, the tumor stained posi-
tively for CD34 (Figure 2B) and negatively for
CD117, cytokeratins, desmin, S100 protein, and
HMB-45, which is typical for a JCT.
On the first postoperative day, the PRA de-
creased to 0.34 ng/mL/hr. By contrast, the blood
pressure fluctuated, with a descending trend pos-
toperatively, and then attained stable normoten-
sion after the 5th postoperative day, without
medication. At outpatient follow-up, 1 month after
discharge from hospital, her blood pressure was
120/70 mmHg, plasma potassium level was 4.0
mmol/L, and random PRA was 1.16 ng/mL/hr.
Discussion
JCT, a rare renal neoplasm, was first described in
1967 by Robertson et al.1 The incidence of this
Figure 1. Computed tomography showed a tumor with low
attenuation localized in the middle pole of the left kidney
(arrow).
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tumor is very low, with only 95 cases reported in
the published literature to date. The occurrence of
JCT has a peak incidence in the 2nd and 3rd decades
of life, and is rarely included in the causes of hy-
pertension in children.3 All of the reported JCT
cases were benign in nature, except for that of one
patient who had an ischemic bowel due to ma-
lignant hypertension.4 The diagnosis of JCT is clin-
ically imperative because of the possible long-term
risk of cardiovascular and renal diseases caused
by its accompanying hypertension.
JCT presents with a clinical triad of hyperten-
sion, hypokalemia, and an elevated plasma renin
level (or activity).2 Although there is obesity and
a family history of hypertension associated with
this patient, other factors, such as the age of onset,
severity of hypertension, and the accompanying
hypokalemia, all raise concerns of secondary hy-
pertension. The causes of secondary hypertension
in adolescents include renal parenchymal/vascular
diseases, endocrine disorders, and coarctation of
the aorta. Because the patient had a high level of
PRA, we believed that she was most likely to have
renovascular disease, a renin-secreting tumor, 
or pheochromocytoma, which was considered
because of its possible co-occurrence with renal
artery stenosis.5
Several diagnostic ambiguities were encoun-
tered for this case. First, acute inhibition by cap-
topril caused an unexpected decrease of PRA and
unexpected increase of serum aldosterone level.
A response to captopril challenge among indi-
viduals with JCT is usually not present due to the
loss of the negative feedback control mechanism.
However, some investigators do not agree with this
theory. Corvol et al observed an increase of PRA
after captopril intake in four patients, but a de-
crease in two.6 By contrast, unlike the paradoxical
response to a pharmacological challenge, our pa-
tient had the typical increase of PRA in response to
postural change. This variability of PRA response
to different procedures could be attributed to the
fact that the renin secretion in JCT is affected by
different factors, such as sympathetic drive, pos-
ture, sodium balance, and angiotensin II negative
feedback.7
Unlike typical cases of JCT, our patient had
normal serum aldosterone levels despite excess
production of renin. Impaired elevation of serum
aldosterone level in hyper-reninism is observed
in several clinical conditions, such as aldosterone
synthase deficiency, critical liver cirrhosis, plasma
exchange, and metastatic carcinoma of the adrenal
gland.8 Our patient’s healthy history and current
physical status were not suggestive of these condi-
tions. Since aldosterone secretion is primarily reg-
ulated by the renin-angiotensin system and serum
potassium, we presumed that the stimulating effect
of renin on aldosterone secretion was weaker than
the inhibiting effect of hypokalemia. We suspected
that hypokalemia of long duration led to direct
inhibition of aldosterone secretion in our patient.
A B
Figure 2. (A) The tumor developed with a characteristic hemangiopericytic pattern (black arrow; hematoxylin & eosin;
original magnification, 100×). (B) Juxtaglomerular tumor cells are diffusely and strongly immunoreactive for CD34 (white
arrowhead, original magnification, 200×).
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Computed tomography is the most useful
tool to document the presence of a renal mass,
with a sensitivity approaching 100%. Magnetic
resonance imaging and magnetic resonance an-
giography also provide useful initial data.9 We
emphasize that the images derived from these
non-invasive studies are purely descriptive, since
any mass found must be proven by renal vein
sampling or surgical pathology to determine if
the observed renal mass is relevant to the over-
production of renin.
The positive observation of PRA upon renal ve-
nous sampling is also low and is reported in only
64% of patients with JCT.10 For our patient, PRA
sampling also revealed absence of lateralization
of PRA. This could be attributed to peripheral
tumor localization, with venous drainage to the
pericapsular vein instead of the main renal vein,
or to the high levels of angiotensin II in the arte-
rioles of the tumor.7
The microscopic studies of our patient’s tu-
mor are consistent with recent immunohisto-
chemical findings for the majority of JCTs which
show positive staining for CD34 but not for cy-
tokeratins, desmin, S100 protein, or HMB-45.11
Such histologic appearance is typical and helps
to clearly differentiate JCT from other renal tu-
mors, such as renal cell carcinoma (positive cy-
tokeratin staining), angiomyolipoma (positive
HMB-45 staining) and hemangiopericytoma
(negative CD34 staining). CD117 has also been
proposed as another marker for JCT. Neverthe-
less, Ren et al reported negative findings of CD117
immunochemical staining of JCTs.12 Studies for
CD117 expression are necessary to further evalu-
ate the diagnostic utility of CD117 in conjunc-
tion with CD34 as an indicator of JCT.
In conclusion, JCT-related hypertension is
rare but curable. After excluding the possibility
of renal artery stenosis, the clinician must con-
sider the existence of JCT in individuals with
high levels of PRA. Diagnostic imaging studies
using computed tomography, magnetic reso-
nance imaging, or magnetic resonance angiogra-
phy are imperative to define and localize the
tumor mass. Prompt removal of JCTs yields good
prognoses.
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